英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
avibactam
|
1192500-31-4 |
硫酸单[(1R,2S,5R)-2-(氨基羰基)-7-氧代-1,6-氮杂双环[3.2.1]辛-6-基]酯
|
硫酸单[(1R,2S,5R)-2-(氨基羰基)-7-氧代-1,6-氮杂双环[3.2.1]辛-6-基]酯;阿维巴坦酸;阿维巴坦杂质37;硫酸单[(1R,2S,5R)-2-(氨基羰基)-7-氧代-1,6-氮杂双环[3.2.1]辛-6-基]酯;阿维巴坦中间体FREE ACID;AVIBACTAM FREE ACID (NXL-104 FREE ACID)
|
C7H11N3O6S |
265.24374 | |
KX2-391
|
897016-82-9 |
5-[4-[2-(4-吗啉基)乙氧基]苯基]-N-(苯基甲基)-2-吡啶乙酰胺
|
CS-234;5-[4-[2-(4-吗啉基)乙氧基]苯基]-N-(苯基甲基)-2-吡啶乙酰胺;KX2-391;KX2 391;KX2391
|
C26H29N3O3 |
431.52676 | 200-258-5 |
CCT129202
|
942947-93-5 |
2-[4-[6-氯-2-(4-二甲基氨基苯基)-3H-咪唑并[4,5-B]吡啶-7-基]哌嗪-1-基]-N-(噻唑-2-基)乙酰胺
|
CS-407;2-[4-[6-氯-2-(4-二甲基氨基苯基)-3H-咪唑并[4,5-B]吡啶-7-基]哌嗪-1-基]-N-(噻唑-2-基)乙酰胺
|
C23H25ClN8OS |
497.03 | |
2'-O-beta-L-Galactopyranosylorientin
|
861691-37-4 |
荭草素-2"-O-BETA-L-半乳糖苷
|
2-(3,4-Dihydroxyphenyl)-8-(2-O-beta-L-galactopyranosyl-beta-D-glucopyranosyl)-5,7-dihydroxy-4H-1-Benzopyran-4-one;2''-O-beta-L-Galactopyranosylorientin;2";-O-beta-L-galactopyranosylorientin;2"-O-β-L-Galorientin;Orientin-2''-O-β-L-galactoside;2,2-Bis(hydroxymethyl)-2,2';-nitrilotriethanol 99+%
|
C27H30O16 |
610.5175 | |
4-[2-Amino-6-[(1R)-1-[4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]-4-pyrimidinyl]-L-phenylalanine ethyl ester N-benzoylglycine salt
|
1137608-69-5 |
4-[2-氨基-6-[(1R)-1-[4-氯-2-(3-甲基-1H-吡唑-1-基)苯基]-2,2,2-三氟乙氧基]-4-嘧啶基]-L-苯丙氨酸乙酯 N-苯甲酰甘氨酸盐
|
LX1606马尿酸盐;CS-373;LX1606 HIPPURATE;TELOTRISTAT ETIPRATE;LX-1606 HIPPURATE;TELOTRISTAT ETIPRATE;LX 1606 HIPPURATE;LX-1606 HIPPURATE;马尿酸盐,LX 1606;4-[2-氨基-6-[(1R)-1-[4-氯-2-(3-甲基-1H-吡唑-1-基)苯基]-2,2,2-三氟乙氧基]-4-嘧啶基]-L-苯丙氨酸乙酯 N-苯甲酰甘氨酸盐;LX 1606 马尿酸盐
|
C36H35ClF3N7O6 |
754.15461 | |
Vemurafenib
|
918504-65-1 |
维罗非尼
|
维罗菲尼;威罗菲尼;维罗非尼,VEMURAFENIB;唯罗非尼;维罗非尼,RG7204
|
C23H18ClF2N3O3S |
489.9221264 | |
Zonisamide
|
68291-97-4 |
唑尼沙胺
|
1,2-苯并异嗯唑-3-甲磺胺;佐尼沙胺;唑利磺胺;唑尼沙胺;1-(1,2-苯并唑-3-基)甲基磺酰胺;1-(1,2-苯并噁唑-4-基)甲基磺酰胺
|
C8H8N2O3S |
212.22572 | 614-395-8 |
PH-797804
|
586379-66-0 |
3-溴-4-(2,4-二氟苄氧基)-1-[5-[(甲基氨基)羰基]-2-甲基苯基]-6-甲基吡啶-2(1H)-酮
|
3-溴-4-(2,4-二氟苄氧基)-1-[5-[(甲基氨基)羰基]-2-甲基苯基]-6-甲基吡啶-2(1H)-酮;CS-45;PH 797804;PH797804
|
C22H19BrF2N2O3 |
477.298666 | |
TAK-901
|
934541-31-8 |
5-[3-(乙基磺酰基)苯基]-3,8-二甲基-N-(1-甲基-4-哌啶基)-9H-吡啶并[2,3-B]吲哚-7-甲酰胺
|
TAK-901;CS-7;5-[3-(乙硫酰基)苯基]-3,8-二甲基-N-(1-甲基-4-哌啶基)-9H-吡啶并[2,3-B]吲哚-7-甲酰胺;5-[3-(乙基磺酰基)苯基]-3,3-B]吲哚-7-羧酰胺;5-[3-(乙基磺酰基)苯基]-3,3-B]吲哚-7-甲酰胺
|
C28H32N4O3S |
505 | |
JNJ 303
|
878489-28-2 |
2-(4-Chlorophenoxy)-2-methyl-N-[5-[(methylsulfonyl)amino]tricyclo[3.3.1.13,7]dec-2-yl]-propanamide
|
|
C21H29ClN2O4S |
440.98396 | |
LY2940680
|
1258861-20-9 |
4-氟-N-甲基-N-[1-[4-(1-甲基-1H-吡唑-5-基)-1-酞嗪基]-4-哌啶基]-2-(三氟甲基)苯甲酰胺
|
LY 2940680;LY2940680;4-氟-N-甲基-N-[1-[4-(1-甲基-1H-吡唑-5-基)-1-酞嗪基]-4-哌啶基]-2-(三氟甲基)苯甲酰胺(LY2940680);4-氟-N-甲基-N-[1-[4-(1-甲基-1H-吡唑-5-基)-1-酞嗪基]-4-哌啶基]-2-(三氟甲基)苯甲酰胺
|
C26H24F4N6O |
512.51 | |
2-Deoxy-D-glucose
|
154-17-6 |
2-脱氧-D-葡萄糖
|
D-2-脱氧葡萄糖;2-去氧-D-葡萄糖;2-脱氧葡萄糖;2-去氧-D-葡糖;2-脱氧-D-葡糖;2-去氧-D-葡萄糖,98%;2-去氧-D-葡萄糖,D-2-脱氧葡萄糖;2-脱氧-D-葡萄糖
|
C6H12O5 |
164.16 | 205-823-0 |
Canagliflozin
|
842133-18-0 |
卡格列净
|
坎格列净(TA 7284,JNJ 28431754);卡那氟星;坎格列净;卡格列净;卡格列净(坎格列净);坎格列净:卡格列净;卡格列净杂质112;CS-183
|
C24H25FO5S |
444.516 | 695-192-1 |
TW-37
|
877877-35-5 |
N-[4-(2-叔丁基苯磺酰基)苯基]-2,3,4-三羟基-5-(2-异丙基苯基甲基)苯甲酰胺
|
4-三羟基-5-(2-异丙基苯基甲基)苯甲酰胺;N-[4-(2-叔丁基苯磺酰基)苯基]-2;CS-299;TW37;TW 37;N-[4-(2-叔丁基苯磺酰基)苯基]-2,3,4-三羟基-5-(2-异丙基苯基甲基)苯甲酰胺;N-[4-(2-叔丁基苯磺酰基)苯基]-2,4-三羟基-5-(2-异丙基苯基)苯甲酰胺;N-[4-(2-叔丁基苯磺酰基)苯基]-2,4-三羟基-5-(2-异丙基苄基)苯甲酰胺
|
C33H35NO6S |
573.6991 | |
Betrixaban
|
330942-05-7 |
贝曲西班
|
贝曲西班;N-(5-氯-2-吡啶基)-2-(4-(N,N-二甲基甲脒基苯甲酰氨基)-5-甲氧基苯甲酰胺;贝曲沙班;贝曲西班>98%
|
C23H22N5O3Cl |
451.90548 | 682-459-2 |
R406 (freebase)
|
841290-80-0 |
R-406
|
R406;R-406;6-[[5-氟-2-[(3,4,5-三甲氧基苯基)氨基]-4-嘧啶基]氨基]-2,2-二甲基-2H-吡啶并[3,2-B]-1,4-恶嗪-3(4H)-酮;R406(游离的);6-[[5-氟-2-[(3,4-噁嗪-3(4H)-酮;R788中间体3;R406 (FREE BASE);R-406;CS-214;R406 福他替尼中间体
|
C22H23FN6O5 |
470.459 | 617-533-5 |
Foretinib (GSK1363089, XL880)
|
849217-64-7 |
Foretinib (GSK1363089)
|
XL-880;EXEL-2880;XL 880;(试剂)FORETINIB (GSK1363089,XL880);1-N'-[3-FLUORO-4-({6-METHOXY-7-[3-(MORPHOLIN-4-YL)PROPOXY]QUINOLIN-4-YL}OXY)PHENYL]-1-N-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE;XL-880;GSK089;EXEL-2880;XL 880;GSK-089;GSK 1363089;GSK-1363089;N-[3-氟-4-[[6-甲氧基-7-[[3-(吗啉-4-基)丙基]氧]喹啉-4-基]氧]苯基]-N'-(4-氟苯基)环丙烷-1,1-二甲酰胺;FORETINIB GLAXOSMITHKLINE PAPILLARY RENAL CELL CARCINOMA PHASE IIRSCH. TRIANGLE PARK,NC (SEE ALSO HEAD;NECK)(888)825-5249;GSK1363089;FORETINIB;EXEL-2880
|
C34H34F2N4O6 |
632.653766 | |
BIX02188
|
1094614-84-2 |
3-[[[3-[(二甲基氨基)甲基]苯基]氨基]苯基亚甲基]-2,3-二氢-2-氧代-1H-吲哚-6-甲酰胺
|
CS-38;3-[[[3-[(二甲基氨基)甲基]苯基]氨基]苯基亚甲基]-2,3-二氢-2-氧代-1H-吲哚-6-甲酰胺;BIX 02188(BIX-02188;BIX02188)
|
C25H24N4O2 |
412.48366 | |
Teriflunomide
|
163451-81-8 |
特立氟胺
|
特瑞氟米特杂质;来氟米特杂质1;来氟米特EP杂质B;N-(4-三氟甲基)-2-氰基-3-羟基巴豆酰胺;特立氟胺;特立氟胺杂质
|
C12H9N2O2F3 |
270.20726 | 642-273-4 |
Tedizolid
|
856866-72-3 |
特地唑胺
|
(R)-3-(3-氟-4-(6-(2-甲基-2H-四唑-5-基)吡啶-3-基)苯基)-5-(羟甲基)恶唑烷-2-酮,特地唑胺;特地唑胺杂质7;CS-1826;TOREZOLID-21;泰地唑利;特地唑胺游离碱;磷酸特地唑胺TR-700;TEDIZOLID;TR-700;DA-7158
|
C17H15N6O3F |
370.3378 | 815-370-6 |